Moderator: David A. Kooby, MD, FACS, Atlanta, GA
Co-Moderator: Peter J. Allen, MD, FACS, New York, NY

The widespread use of cross-sectional imaging (ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI)) has led to an explosion in the discovery of asymptomatic pancreatic lesions over the past two decades the pancreatic incidentaloma. This panel will focus on the evaluation of incidentally discovered pancreatic lesions cystic (mutinous and serous lesions, intraductal pancreatic mutinous neoplasms true cysts, and pseudocysts) and solid lesions (pancreatic neuroendocrine tumors). Selection criteria for observation, interventional evaluation, and surgical management will be discussed.

Presentations and Speakers

Introduction and Overview
Peter J. Allen, MD, FACS and David Kooby, MD, FACS

A Primer to Understanding Pancreatic Lesions on CT and MRI
Aarti Sekhar, MD, Atlanta, GA

Risk Assessment: Who and How 
Maria C. Russell, MD, FACS, Atlanta, GA

Making Sense of Intraductal Papillary Mucinous Neoplasms (IPMN) 
Syed A. Ahmad, MD, FACS, Cincinnati, OH

Small Pancreatic Neuroendocrine Tumors: To Cut or Not to Cut
Ajay V. Maker, MD, FACS, Chicago, IL

Case Presentations: Pancreatic Incidentalomas
David A. Kooby, MD, FACS, Atlanta, GA